KristinA.(Ammon)ShimanoMD

Pediatric Hematology & Oncology • San Francisco, CA

HS Clinical Associate Professor University of California, San Francisco

Join to view full profile

Dr. Shimano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shimano's full profile

Already have an account?

Office
505 Parnassus Ave
# 0106
San Francisco, CA 94143
Phone+1 415-476-3831

Education & Training

University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2008 - 2010
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2008
University of California (San Francisco)Residency, Pediatrics, 2003 - 2007
Harvard Medical SchoolClass of 2003

Certifications & Licensure

CA State Medical License 2005 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Start of enrollment: 2019 May 02
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

1205 citations
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang, Li Ding, Linda Holmfeldt, Gang Wu, Susan L. Heatley
Nature. 2012-01-12
47 citations
Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy.
Emily A. Edwards, Andrew Phelps, Daniel L Cooke, Ilona J. Frieden, Matthew A. Zapala
Pediatrics. 2020-09-01
85 citations
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.
Catharina Schuetz, Manfred Hoenig, Despina Moshous, Christof Weinstock, Martin Castelle
Blood Advances. 2018-10-09

Abstracts/Posters

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis
Kristin A. Shimano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants
Kristin A. Shimano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Bangladesh-Boston Collaborate on ASCT CenterDecember 5th, 2016
The AMA Does Not Speak for UsDecember 9th, 2016